Gov. O'Malley: One Maryland's Economic Leadership, Progress

Maryland Moves Up to #2 in Biotech Economy

O'Malley/Brown Secure Economic Advantage

O'Malley/Brown - Maryland Increases its "Bio Power"
"Maryland moved up (2nd in the nation) from fourth in this year's ranking, thanks to strong positions across the many indicators used by the Institute. In particular, the report cited an improvement in the ability to attract business into the state and new projects that link research institutions with industry to produce the most advanced products." [Milken Institute, 6.19.08]

"The results of the Milken Institute study are further evidence that Maryland is highly and increasingly competitive in drawing, retaining, and growing technology-based businesses." [Milken Institute, 6.19.08]
Gov. Martin O'Malley

Doing More - $1.1 Billion Biotech Investment
"Maryland business executives lauded Gov. Martin O'Malley's new biotechnology initiative that calls for the state to invest an unprecedented $1.1 billion in the industry over the next decade." [Gazette, 6.19.08]

"Calling it a ''sound investment," state officials, researchers and stem cell advocates on Monday praised a plan for Maryland to invest $1.1 billion in the biotechnology industry over the next decade." [Gazette, 6.18.08]

''We seek to take a giant step forward in harnessing all the potential that is already within our grasp… Bioscience is, in many ways, the key to unlocking our future economic potential as a state... We are uniquely positioned among states for even greater leadership, not just within the continental United States, but within the whole world." [Gazette, 6.18.08]
Gov. Martin O'Malley

"If we in Maryland are willing to invest in the here and now of our bioscience economy, then together we can become a leader in this new scientific frontier." [Washington Post, 6.17.08]
Gov. Martin O'Malley

Business Applauds O'Malley/Brown Vision for Future
''This is a good time for the governor to be showing that Maryland is stepping up and moving up to the big leagues." [Gazette, 6.19.08]
Steve Bende, President and CEO, Bacilligen

"It's been a great program for us and a number of other biotechnology companies I know of... 'It has mitigated some of the risk of investing in biotechs and helped gain a greater pool of investors." [Gazette, 6.19.08]
Marty Zug, CFO, Sequella

''There is a significant industry presence in the state, [and] no other state can match our medical research capacity… Our proximity to federal agencies is unique, and our population is highly educated. Gov. O'Malley's vision for bioscience and the corresponding commitment of state resources can propel us as a top-tier state in this very competitive industry." [Gazette, 6.19.08]
Donald Fry, President and CEO, Greater Baltimore Committee

"These are not flash-in-the pan investments… They are a continuation of the actions taken through many generations of work, to make us one of the strongest states in the union." [Washington Post, 6.17.08]
Gov. Martin O'Malley